Th17 mediators and vitamin D status by Krstić, Goran
In their study on Th  1 and Th  17 hypercytokinemia in 
severe pandemic inﬂ  uenza, Bermejo-Martin and colleagues 
[1] observed signiﬁ   cantly elevated levels of IL-17 and 
par  ticularly IL-6 in critically ill patients. Th  ey also 
reported that up to 50% of critical care patients studied 
were obese.
Correale and colleagues [2] indicate that activated 
vitamin D enhances the development of IL-10-producing 
cells and reduces the number of IL-6- and IL-17-
secreting cells. Studies show that obese and overweight 
individuals are more likely to have an inadequate vitamin 
D status [3,4]. According to Louie and colleagues [5], 
diabetes and obesity were the most frequently identiﬁ  ed 
underlying conditions in fatal pandemic 2009 inﬂ  uenza A 
(H1N1) infection cases older than age 20 years 
world  wide. In addition, obese people usually have high 
calorie and low nutritional value diets. Aasheim and 
colleagues [6] showed that low concentrations of vitamin 
B-6, vitamin C, 25-hydroxyvitamin  D, and vitamin E 
adjusted for lipids are prevalent in morbidly  obese 
Norwegian patients seeking weight-loss treatment.
It would be interesting to see if any of the critical cases 
observed in the study by Bermejo-Martin and colleagues 
were insuﬃ   cient or deﬁ  cient in vitamin D and/or other 
nutrients relevant for intracellular signaling involved in 
inﬂ  ammation. If vitamin D plays a role in human general 
capacity to deal with infection and other diseases, then 
an increase in Th  17 mediators in severe pandemic 
inﬂ  uenza patients could be, at least in part, related to 
vitamin D insuﬃ   ciency/deﬁ  ciency.
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Jesus F Bermejo-Martin and the SEMICYUC H1N1 working group
We appreciate Dr Krstić’s comment on our article on 
Th  1-Th   17 hypercytokinemia in severe pandemic 
inﬂ  uenza, recently published in Critical Care. Dr Krstić 
points to deﬁ  ciency of vitamin D as a potential actor in 
the disregulation of the immune response to the new 
virus. In our opinion, this could represent a new avenue 
to be explored in the pathogenesis of the disease. 
Nonetheless, some questions come to mind. If obesity is 
related to a deﬁ   cient state of vitamin D, and, as a 
consequence, this deﬁ   ciency could inﬂ  uence  the 
inﬂ  ammatory response to the virus, higher numbers of 
critically ill H1N1 patients should be observed in western 
countries, where obesity is widely present. Other 
countries should also account for increased numbers of 
critical patients due to vitamin D deﬁ  ciency: developing 
countries or those with limited exposure to sun light are 
two examples. So far, data do not seem to support an 
overwhelming increased incidence of severe H1N1 
disease in these nations. In our view, vitamin D deﬁ  ciency 
could be involved in the genesis of severe inﬂ  uenza 
disease, but host factors, such as key polymorphisms in 
the genes responsible for the response to the virus, are 
the major players in this disease [7], probably combined 
with the presence of altered physiological states 
(increased release of proinﬂ   ammatory mediators from 
adypocytes in obese patients [8], immune dysregulation 
in pregnancy [9], mucosal inﬂ   amation in chronic 
obstructive pulmonary disease and smokers [10], and so 
on). Vitamin D should thus be considered in the context 
of a wider spectrum of factors inﬂ  uencing severe disease.
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